Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08091f01870518e30210ba8cc7924832 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11bb341b083230e7bd42e8c5a0121b62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f862a47e0ff4caf61f3ea9b6eb0d2b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff3736f86a2c378cdc62f587bf1f284b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5f694ab37a0a3c644121607756f972f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d2eec75d186b3187cd2cf6799d4032f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-03001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
filingDate |
2008-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea0cda7310127baa124341b439c9d9e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb1cf4b61e5aab181559e66017335cd9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ad7e2fb5560b45dff80950d9645041c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a249de75cb98abcb3e212641d9ee3f1a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fd0512cc63a0fa9a9c30fd15d607f1e |
publicationDate |
2013-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8586032-B2 |
titleOfInvention |
Use of alkaline phosphatase in the treatment of reduced renal function |
abstract |
The invention relates to the field of medicine and in particular to the use of alkaline phosphatase in the treatment of renal diseases, such as reduced renal function. The present invention also relates to the field of pharmacy and in particular to the pharmaceutical use of alkaline phosphatase. The present invention provides an alternative treatment to improve a situation in which the renal function is reduced by using alkaline phosphatase. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11338020-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10822597-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654184-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014193388-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9926544-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11638699-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11746340-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10570380-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019172766-A1 |
priorityDate |
2007-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |